In vitro activities of four novel triazoles against Scedosporium spp
about
Mucormycosis, pseudallescheriasis, and other uncommon mold infectionsMelanized fungi in human diseaseInfections caused by Scedosporium spp.Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsMonoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungusMolecular Phylogeny of the Pseudallescheria boydii Species Complex: Proposal of Two New SpeciesScedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies.In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.New developments in chemotherapy for non-invasive fungal infections.Disseminated phaeohyphomycosis: review of an emerging mycosis.Review of the safety and efficacy of voriconazole.In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.Voriconazole: a new triazole antifungal agent.In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.Voriconazole in the management of nosocomial invasive fungal infections.Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideMycetoma medical therapy.Scedosporium species infections and treatments.Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adultsPosaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazoleEffect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.Emerging azole antifungals.Posaconazole: clinical pharmacology and potential for management of fungal infections.Therapy of infections caused by dematiaceous fungi.Activity of posaconazole in the treatment of central nervous system fungal infections.Fungal CNS infections in patients with hematologic malignancy.Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injuryPharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy menNewer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.Dematiaceous fungi.Nosocomial fungal infections: epidemiology, diagnosis, and treatment.Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.Biochemical characterization of potential virulence markers in the human fungal pathogen Pseudallescheria boydii.Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.New generation azole antifungals in clinical investigation.
P2860
Q24603297-D535C47A-ED82-47E6-B7BB-A944E721F156Q24633163-D3A0C3E3-3A45-43FF-81E1-916822C18FF4Q24657691-B5899494-72DB-495A-AFBA-555823694D45Q27025299-F3A37C92-5503-4E90-8815-CE678672A71BQ27306696-556D6F26-373F-40EA-813F-F8225337C624Q28315329-A27C0245-89E2-4450-B934-8B3252DC3446Q28315344-EA35C9F1-EC38-4D1C-9132-790B870D50E6Q33392206-7CFB7B5D-7B7E-45D9-9C37-B603EF843167Q34143259-0771FBDE-F57B-4D5D-88A4-A875334DCD46Q34481647-818A3856-E79D-4B84-AA13-B37E9FA4AACCQ34498615-0997D429-E3BC-4726-B583-8CAA7BF4A6B1Q34544679-EDDE4F43-17CF-4EB1-BA42-2A97D191A92DQ34680661-8AA7DC12-BC71-4BB8-AB2C-7251528A92FFQ35069136-8475CB69-A601-4A16-AE7F-432F5A91DE43Q35103898-3EC1BBD1-116E-4E92-8DDB-C8183D6CF24FQ35166823-A0C056BC-9FA5-47AB-BB1E-EE3CC0C7D5CEQ35194598-79088988-2E9F-4713-8C79-31607F9076D8Q35351362-376FAF58-4E68-421A-93DD-F5D17147AFFAQ35622016-0AE36947-2254-4FFA-9215-831D28DB98AAQ35685548-BD21EA47-A919-4FD4-A0F1-C571EFE71096Q35732778-3123A0E6-46CF-498C-B00E-00027C3B270AQ35825919-BFA58967-752B-4B1C-A7A1-F6F19AEF9D96Q36066009-B170E057-9105-437A-BB28-2C81EDD94B48Q36233491-303565BB-32FF-4EFF-8FCF-D5EAD02840A8Q36233517-13880F4C-9260-4B09-9BDD-DC08B64AFE5BQ36246196-E842E267-F016-4E67-864A-029EA7FB873AQ36278069-C36310C3-CBEE-4473-A933-B324D18D6FE6Q36376608-AFB95A43-3C4F-4EA1-B2EC-91C26477CF7CQ36489989-6C59D114-8C48-4BDC-BA45-ED2505893256Q36491819-2EC020E6-A52C-4229-9B5D-37B3DD375C45Q36669593-ADF1B718-32EE-4105-93FA-CABC31DB2370Q36738130-9EA6BC1C-53C3-4C3B-B699-229BBAABF537Q36825717-E2334EF4-7E26-4BEB-8AB3-B26DB473B724Q37055215-ED6A159A-F87C-49EB-A4E9-360D943FBADBQ37106636-4130925C-7497-4F3B-B9D0-F1CF57627CF9Q37119029-53640F4E-2B18-4783-A0EF-5E8A10FA3619Q37334205-99E9C5F7-5BF0-4983-8A08-760E1717076AQ37398912-ABDA9DC9-9E8E-4B57-87FF-4E4D6CFB8EA0Q37568516-E4073164-52AE-40AA-AFF4-C95F86A8CBEAQ37579222-6078659D-6872-4185-BE7D-E456FDFC7FF9
P2860
In vitro activities of four novel triazoles against Scedosporium spp
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vitro activities of four novel triazoles against Scedosporium spp
@ast
In vitro activities of four novel triazoles against Scedosporium spp
@en
In vitro activities of four novel triazoles against Scedosporium spp
@nl
type
label
In vitro activities of four novel triazoles against Scedosporium spp
@ast
In vitro activities of four novel triazoles against Scedosporium spp
@en
In vitro activities of four novel triazoles against Scedosporium spp
@nl
prefLabel
In vitro activities of four novel triazoles against Scedosporium spp
@ast
In vitro activities of four novel triazoles against Scedosporium spp
@en
In vitro activities of four novel triazoles against Scedosporium spp
@nl
P2860
P1476
In vitro activities of four novel triazoles against Scedosporium spp
@en
P2093
A J Carrillo
P2860
P304
P356
10.1128/AAC.45.7.2151-2153.2001
P407
P50
P577
2001-07-01T00:00:00Z